Seth Thompson

2.3k total citations
27 papers, 1.8k citations indexed

About

Seth Thompson is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Seth Thompson has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Seth Thompson's work include Cancer Immunotherapy and Biomarkers (5 papers), Hepatitis C virus research (5 papers) and CAR-T cell therapy research (4 papers). Seth Thompson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Hepatitis C virus research (5 papers) and CAR-T cell therapy research (4 papers). Seth Thompson collaborates with scholars based in United States, Italy and France. Seth Thompson's co-authors include Daniel P. Petrylak, Alan Yagoda, Steven D. Stellman, Joshua Muscat, E L Wynder, John P. Richie, Donald J. Cohen, Paul McBride, Margaret E. Hertzig and Dietrich Hoffmann and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Seth Thompson

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seth Thompson United States	19	473	324	315	305	282	27	1.8k
Sung Hwan Kim South Korea	25	666 1.4×	540 1.7×	602 1.9×	267 0.9×	76 0.3×	137	2.1k
George Koukoulis Greece	35	389 0.8×	407 1.3×	932 3.0×	684 2.2×	348 1.2×	134	3.5k
E. Klieser Austria	24	415 0.9×	155 0.5×	245 0.8×	356 1.2×	62 0.2×	91	1.6k
Manuel González Barón Spain	27	817 1.7×	394 1.2×	389 1.2×	391 1.3×	65 0.2×	141	2.3k
Shona Lang United Kingdom	26	1.2k 2.5×	820 2.5×	335 1.1×	905 3.0×	41 0.1×	56	3.8k
Yu‐Chiau Shyu Taiwan	22	173 0.4×	113 0.3×	153 0.5×	604 2.0×	104 0.4×	76	1.6k
Feras Zaiem United States	15	140 0.3×	183 0.6×	199 0.6×	292 1.0×	501 1.8×	34	1.4k
Fuquan Wu China	16	311 0.7×	88 0.3×	155 0.5×	638 2.1×	330 1.2×	22	1.7k
Katherine M. Sheehan Ireland	24	421 0.9×	182 0.6×	330 1.0×	656 2.2×	39 0.1×	67	1.9k
Lu Yin China	23	273 0.6×	122 0.4×	99 0.3×	220 0.7×	56 0.2×	55	1.8k

Countries citing papers authored by Seth Thompson

Since Specialization

Citations

This map shows the geographic impact of Seth Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Thompson more than expected).

Fields of papers citing papers by Seth Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Thompson. The network helps show where Seth Thompson may publish in the future.

Co-authorship network of co-authors of Seth Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Seth Thompson. A scholar is included among the top collaborators of Seth Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth Thompson. Seth Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zinzani, Pier Luigi, Catherine Thiéblemont, В Я Мельниченко, et al.. (2023). Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170. Blood. 142(2). 141–145. 31 indexed citations

Zinzani, Pier Luigi, Catherine Thiéblemont, В Я Мельниченко, et al.. (2021). Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL). Blood. 138(Supplement 1). 306–306. 5 indexed citations

Zinzani, Pier Luigi, В Я Мельниченко, Krimo Bouabdallah, et al.. (2020). Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study. Blood. 136(Supplement 1). 42–43. 1 indexed citations

Palumbo, Antonio, María‐Victoria Mateos, Jesús F. San Miguel, et al.. (2016). KEYNOTE-185: a randomized, open-label phase 3 study of pembrolizumab in combination with lenalidomide and low-dose dexamethasone in newly diagnosed and treatment-naive multiple myeloma (MM).. Journal of Clinical Oncology. 34(15_suppl). TPS8069–TPS8069. 7 indexed citations

Howe, A, Jianmin Long, David C. Nickle, et al.. (2014). Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C. Antiviral Research. 113. 71–78. 19 indexed citations

Sulkowski, Mark, Stanislas Pol, Josep Mallolas, et al.. (2013). Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial. The Lancet Infectious Diseases. 13(7). 597–605. 142 indexed citations

Bruno, Savino, John M. Vierling, Rafael Esteban, et al.. (2012). Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis. Journal of Hepatology. 58(3). 479–487. 40 indexed citations

Thompson, Seth, et al.. (2004). Adherence to a low-fat diet in men with prostate cancer. Urology. 64(5). 970–975. 13 indexed citations

Douillard, Jean‐Yves, Paulo M. Hoff, Jamey Skillings, et al.. (2002). Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer. Journal of Clinical Oncology. 20(17). 3605–3616. 249 indexed citations

10.

Guttenplan, Joseph B., Michael Chen, Wieslawa Kosinska, et al.. (2001). Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Letters. 164(1). 1–6. 54 indexed citations

11.

Melikian, Assieh A., Ray O’Connor, Agasanur K. Prahalad, et al.. (1999). Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry. Carcinogenesis. 20(4). 719–726. 87 indexed citations

12.

McBride, Paul, George Anderson, Margaret E. Hertzig, et al.. (1998). Effects of Diagnosis, Race, and Puberty on Platelet Serotonin Levels in Autism and Mental Retardation. Journal of the American Academy of Child & Adolescent Psychiatry. 37(7). 767–776. 112 indexed citations

13.

Stellman, Steven D., Joshua Muscat, Seth Thompson, Dietrich Hoffmann, & Ernst L. Wynder. (1997). Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer. 80(3). 382–388. 127 indexed citations

14.

Tordjman, Sylvie, Paul McBride, Margaret E. Hertzig, et al.. (1997). Plasma β‐Endorphin, Adrenocorticotropin Hormone, and Cortisol in Autism. Journal of Child Psychology and Psychiatry. 38(6). 705–715. 116 indexed citations

15.

DiPaola, Robert S., Robert E. Weiss, Kenneth B. Cummings, et al.. (1997). Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen.. PubMed. 3(11). 1999–2004. 18 indexed citations

16.

Chen, Jonathan M., Alan Weinberg, Eric A. Rose, et al.. (1996). Multivariate analysis of factors affecting waiting time to heart transplantation. The Annals of Thoracic Surgery. 61(2). 570–575. 31 indexed citations

17.

Richie, John P., et al.. (1996). Gender differences in smoking and risk for oral cancer.. PubMed. 56(22). 5192–7. 111 indexed citations

18.

Mason, Barbara J., James H. Kocsis, Andrew C. Leon, et al.. (1993). Measurement of Severity and Treatment Response in Dysthymia. Psychiatric Annals. 23(11). 625–631. 60 indexed citations

19.

Yagoda, Alan, Daniel P. Petrylak, & Seth Thompson. (1993). CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL CELL CARCINOMA. Urologic Clinics of North America. 20(2). 303–321. 158 indexed citations

20.

Karp, Barbara I., et al.. (1991). A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biological Psychiatry. 30(4). 417–420. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact